How should I manage a patient with acute on chronic kidney injury who now has hyperkalemia, hyperphosphatemia, an anion gap of 13, and an eGFR of about 30 mL/min/1.73 m²?

Immediate Hospitalization Required for Acute Kidney Injury with Hyperkalemia

This patient requires urgent hospital admission for acute kidney injury (AKI) management, with immediate evaluation for potential dialysis given the rapid decline in renal function, hyperkalemia at 5.5 mmol/L, and eGFR drop from 56 to 32 mL/min/1.73m² in just two weeks 1.

Immediate Actions Upon Admission

1. Assess for Life-Threatening Hyperkalemia

• Obtain an ECG immediately to evaluate for cardiac conduction abnormalities, even though severe hyperkalemia can be present without ECG changes 2
• Check for symptoms: muscle weakness, paresthesias, palpitations, or nausea (which may indicate severe hyperkalemia or uremia) 2
• The potassium of 5.5 mmol/L is moderate hyperkalemia but requires urgent attention given the acute renal deterioration

2. Determine AKI Etiology

Classify the AKI as prerenal, intrinsic renal, or postrenal 1:

Essential workup:

• Medication review: Identify nephrotoxic drugs, NSAIDs, recent contrast exposure, or RAAS inhibitors (ACEi/ARB)
• Volume status assessment: Look for signs of dehydration (prerenal) vs. volume overload
• Renal ultrasound: Rule out obstruction (particularly important given the rapid decline) 1
• Urinalysis with microscopy and fractional excretion of sodium (FENa) 1
• Complete blood count, metabolic panel

3. Acute Hyperkalemia Management

Initial treatment approach 3, 4:

• Calcium gluconate or calcium chloride if ECG changes present (cardiac membrane stabilization)
• Insulin/dextrose to shift potassium intracellularly
• Salbutamol (if available) for additional intracellular shift
• Loop diuretics if patient has residual urine output
• Consider novel potassium binders (patiromer or sodium zirconium cyclosilicate) for sustained control 3
• Dialysis if hyperkalemia is refractory or if other urgent indications exist (see below)

Indications for Urgent Dialysis

Initiate renal replacement therapy if any of the following are present 1:

• Refractory hyperkalemia despite medical management
• Volume overload unresponsive to diuretics
• Intractable metabolic acidosis
• Uremic symptoms (encephalopathy, pericarditis, pleuritis)
• Severe azotemia with rapid progression

Given the 59% increase in creatinine over two weeks (from 1.00 to 1.59), this patient is at high risk for requiring dialysis.

Hyperphosphatemia Management

The phosphorus of 5.3 mg/dL represents hyperphosphatemia in the context of CKD 5:

• Initiate phosphate binders with meals (calcium-based or non-calcium-based depending on calcium levels)
• Dietary phosphorus restriction (avoid high-phosphorus foods)
• Note that gastric pH affects phosphate binder efficiency 5

Critical Medication Review

Evaluate RAAS inhibitors 6, 3:

• Do NOT automatically discontinue ACEi/ARB - this is a common pitfall 3
• Per KDIGO 2024 guidelines, continue ACEi/ARB unless creatinine rises >30% within 4 weeks of initiation OR there is uncontrolled hyperkalemia despite medical treatment 6
• Since this is acute deterioration (not related to recent ACEi/ARB initiation), temporarily hold RAAS inhibitors until AKI etiology is determined and renal function stabilizes
• Hyperkalemia should be managed with potassium-lowering strategies rather than discontinuing disease-modifying therapies 3

Stop all nephrotoxic medications 1:

• NSAIDs
• Aminoglycosides
• Other nephrotoxins

Preventing Hyperkalemia Recurrence

Once acute issues are addressed, implement long-term strategies 3, 7:

The goal is to maintain normokalaemia without sacrificing beneficial therapies:

• Dietary counseling: Focus on reducing non-plant sources of potassium rather than strict restriction 3
• Correct metabolic acidosis if present (consider sodium bicarbonate if serum bicarbonate is low)
• Address constipation (increases potassium absorption)
• Consider chronic potassium binders (patiromer or SZC) for patients at high recurrence risk 3, 7
• Note that 43.8% of CKD patients experience hyperkalemia recurrence, with higher rates (49.1%) when eGFR <30 mL/min 7

Common Pitfalls to Avoid

1. Delaying hospitalization: The rapid eGFR decline (from 56 to 32) over two weeks signals acute deterioration requiring urgent evaluation
2. Automatically stopping ACEi/ARB: While temporary hold is reasonable during acute AKI workup, the default should not be permanent discontinuation 3
3. Relying solely on ECG: Severe hyperkalemia can exist without ECG changes 2
4. Ignoring the anion gap: While 13 is only mildly elevated, monitor for developing metabolic acidosis which worsens hyperkalemia
5. Inadequate follow-up: After stabilization, potassium and creatinine should be rechecked within 2-4 weeks 6

Post-Stabilization Plan

Once AKI resolves and patient is stable:

• Resume ACEi/ARB at appropriate dose if indicated for CKD protection (eGFR ≥20 with albuminuria) 6
• Consider SGLT2 inhibitor if eGFR ≥20 mL/min/1.73m² and patient has diabetes, albuminuria ≥200 mg/g, or heart failure 6
• Monitor closely: Recheck creatinine, potassium, and phosphorus within 2-4 weeks 6
• Nephrology referral for ongoing CKD management given eGFR in the 30s range